Market Access is becoming increasingly complex and demanding.

At the same time, this increasing demand on Pharma and Biotech presents opportunities. Opportunities in designing access solutions, and in the pursuit of geographical expansion. Opportunities in developing an appropriate evidence plan and in demonstrating value for money. The limit is ambition, preparation and execution. We are here to assist.

We thrive in assisting biotech and Pharma

Identify, analyze and determine a pricing and access strategy
Develop market access solutions
Develop a health economics research plan or an evidence generation programme
Be more efficient and productive
Understand unfamiliar health care systems
Fill in some gaps in resources
Access new markets and geographies
Implement the strategy, do the negotiation, and get the job done

How we work

At Market Access Advisory, we immerse ourselves in each organization to understand its needs and challenges, identify and analyze options, recommend strategies, and take on projects, short or medium term. We provide temporary additional capability and reach out to unique expertise as needed to ensure successful implementation. Our approach is hands-on and results-driven, with a commitment to delivering value to every project we undertake.

With the Rapid Response Service, we offer the possibility of answering rapidly questions you may have and that do not require extensive research.

Guiding principles

Our guiding principles are centered around delivering results for our clients. We are dedicated to our role in serving our clients and always act with the highest level of ethical behavior. Our commitment to results is unwavering and is reflected in the quality of our work. Our team possesses deep subject matter expertise and leverages this knowledge to add value to every project. We strive to deliver tangible results that drive success for our clients. These principles form the foundation of how we work and drive us to constantly strive for excellence.

Our Services

Market Access Solutions

Market Access solutions can range from determining an adequate pricing strategy, an innovative model to offering patient support program.

Different geographies or health care systems need adapted solutions.

Health Economics strategy planning and study management

HE methods are becoming increasingly elaborate. Likewise, statistical modeling meant to adjust or complement clinical studies is ballooning with increasingly sophisticate methods.

Selecting the appropriate study method and an impactful result dissemination strategy is paramount.

Rapid Response Service

Quick questions service for core Market Access Advisory International services or for services provided by partners and contributors

Organization Structure and capability building

New associates, new research methods, new challenges ensure the dynamism of the enterprise.

Capability development is an essential continuous process

Strategic Pricing, Innovative pricing models

A pricing strategy should address a number of internal objectives and should adhere to local regulations, norms and expectations.

It needs therefore to be adapted to the various markets and to the diverse health care systems in order to ensure optimal market access globally.

RWE, PRO, OR strategy planning

Perhaps no other field is witnessing such tremendous growth as Real-World Evidence (RWE), Patient Reported Outcomes (PRO) and Outcome Research (OR).

Their utilization, influence and impact on market access, clinical research, effectiveness evaluation and regulatory approval continues to expand.

Strategy implementation, stakeholder management and Networking

In the end, all boils down to execution

25+ years of diverse and successful experience

Biography

Jean-Francois Baladi

Develops access solutions for multi-tiered markets, and different health care systems. Integrates market access with commercial and medical activities.

Experienced in pre-launch activities, launch roll-out and life-cycle management.

Successfully dealt with oncology, rare diseases, general medicine environments.

  • Multicultural, multi-region
  • Peer-reviewed publications
  • HTA & economics training, MBA

Local

Pricing and market access head for Canada and Japan.

Regional

Pricing and market access head for APAC, Japan, Latam Middle East

Global

Pricing and market access head for USA & Canada

Some recent projects conducted

Strategic planning on Japan development and pricing potential for a rare disease innovative therapy (EU biotech)
Provided options for market access in China for an established oncology asset (EU biotech)
Presented innovative pricing approaches by various tiered countries (Consulting firm)
Presented Asia – Pacific relative market attractiveness (EU biotech)
Responsible for EU market access launch planning, preparedness and execution for an oncology asset (US biotech)
Developed a Market Access organization structure and EU footprint (US biotech)